イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd, israel - brivaracetam - טבליות מצופות פילם - brivaracetam 25 mg - brivaracetam

イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd, israel - brivaracetam - טבליות מצופות פילם - brivaracetam 50 mg - brivaracetam

イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd, israel - brivaracetam - טבליות מצופות פילם - brivaracetam 75 mg - brivaracetam

イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd, israel - brivaracetam - תמיסה (פומי) - brivaracetam 10 mg / 1 ml - brivaracetam

イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd - polidocanol; soya oil - תמיסה - soya oil 82.95 g / 100 g; polidocanol 15 g / 100 g - polidocanol - polidocanol - refatting medical oil bath with antipruritic effect.

イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd - erythromycin - תמיסה - חיצוני - erythromycin 2 % - erythromycin - erythromycin - all forms of acne, particularly inflammatory forms with papules and pustules.

イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd - erythromycin; tretinoin - תמיסה - erythromycin 4 g / 100 g; tretinoin 0.025 g / 100 g - erythromycin, combinations - erythromycin, combinations - all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules, particularly in the case of fat-rich skin.

イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 50 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 100 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

イスラエル - ヘブライ語 - Ministry of Health

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 150 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.